GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biome Grow Inc (OTCPK:BIOIF) » Definitions » Debt-to-EBITDA

Biome Grow (Biome Grow) Debt-to-EBITDA : -7.72 (As of Sep. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Biome Grow Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Biome Grow's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $3.09 Mil. Biome Grow's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil. Biome Grow's annualized EBITDA for the quarter that ended in Sep. 2023 was $-0.40 Mil. Biome Grow's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was -7.72.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Biome Grow's Debt-to-EBITDA or its related term are showing as below:

BIOIF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.07   Med: -0.24   Max: 30.13
Current: -2.07

During the past 10 years, the highest Debt-to-EBITDA Ratio of Biome Grow was 30.13. The lowest was -2.07. And the median was -0.24.

BIOIF's Debt-to-EBITDA is ranked worse than
100% of 659 companies
in the Drug Manufacturers industry
Industry Median: 1.71 vs BIOIF: -2.07

Biome Grow Debt-to-EBITDA Historical Data

The historical data trend for Biome Grow's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biome Grow Debt-to-EBITDA Chart

Biome Grow Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.32 30.14 11.18 -0.39

Biome Grow Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 -1.76 -0.62 -5.14 -7.72

Competitive Comparison of Biome Grow's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Biome Grow's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biome Grow's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biome Grow's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Biome Grow's Debt-to-EBITDA falls into.



Biome Grow Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Biome Grow's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.059 + 0) / -7.755
=-0.39

Biome Grow's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.088 + 0) / -0.4
=-7.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2023) EBITDA data.


Biome Grow  (OTCPK:BIOIF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Biome Grow Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Biome Grow's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Biome Grow (Biome Grow) Business Description

Traded in Other Exchanges
Address
480 University Avenue, Suite 1401, Toronto, ON, CAN, M5G 1V2
Biome Grow Inc is a Canada-based company engaged in medical and recreational cannabis businesses. Along with its subsidiaries, the firm is engaged in the cultivation of marijuana plants, dried marijuana and marijuana seeds. The company through its Weed VR platform connects customers with growers and distributors as well as retail partners.

Biome Grow (Biome Grow) Headlines